2m 2m 2m 2m 2m 2m 2m
iAnthus Captl Hl (ITHUF)
OTC
$0.005-$0.0001 (-2.04%)
Price as of Jun 03, 2026- $34.2MMarket Cap
- -5.88%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
iAnthus Captl Hl (ITHUF)
$0.005-$0.0001 (-2.04%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 144.0M -14.07% | 167.6M +5.23% | 159.2M -2.44% | 163.2M -19.61% | |
Cost of Revenue | 78.3M -15.32% | 92.5M -3.76% | 96.1M +8.21% | 88.8M -3.22% | |
Gross Profit | 65.7M -12.54% | 75.1M +18.91% | 63.2M -15.13% | 74.4M -33.11% | |
Sales and Marketing Expense | 60.9M -2.08% | 62.2M -20.61% | 78.3M -38.85% | 128.1M +32.09% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 19.3M -22.02% | 24.7M -8.96% | 27.2M -13.44% | 31.4M +1.13% | |
Total Operating Expenses | 81.1M -3.01% | 83.6M -19.50% | 103.9M -44.42% | 186.9M +40.19% | |
Operating Profit | -15.4M +81.10% | -8.5M -79.09% | -40.7M -63.80% | -112.5M +410.58% | |
Interest Income | 13.8M +166.70% | 5.2M +179.31% | 1.8M +2,046.51% | 86,000 -83.37% | |
Interest Expense | -16.6M -3.32% | -17.2M +9.07% | -15.7M -15.61% | -18.7M -20.99% | |
Interest Income and Expense and Net | -2.9M -76.28% | -12.0M -13.54% | -13.9M -25.16% | -18.6M -19.59% | |
Total Nonoperating Income and Expense | -8,000 -82.61% | -46,000 -37.84% | -74,000 -100.54% | 13.7M +772.22% | |
Income before Taxes | -23.2M -8.49% | -25.3M -57.75% | -59.9M -86.34% | -438.7M +712.42% | |
Income Taxes | 17.0M +196.38% | -17.7M -205.86% | 16.7M +56.21% | 10.7M -51.95% | |
Extraordinary Items | N/A N/A | N/A N/A | 0 -100.00% | 30.6M +314.70% | |
Net Income | -40.2M +426.49% | -7.6M -90.03% | -76.6M -82.95% | -449.4M +489.38% | |
Net Income from Continuing Operations Applicable to Common | -23.2M -8.49% | -25.3M -57.75% | -59.9M -86.34% | -438.7M +712.42% | |
Basic EPS and Net Income | -0.01 N/A | 0.00 +100.00% | -0.01 -92.31% | -0.13 -70.45% | |
Diluted EPS and Net Income | -0.01 N/A | 0.00 +100.00% | -0.01 -92.31% | -0.13 -70.45% | |
Basic Weighted Average Shares | 6.7B +2.49% | 6.5B +101,489.96% | 6.4M +90.93% | 3.4M -98.04% | |
Diluted Weighted Average Shares | 6.7B +2.49% | 6.5B +101,489.96% | 6.4M +90.93% | 3.4M -98.04% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 11.7M -37.17% | 18.5M +41.51% | 13.1M -8.59% | 14.3M +8.25% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 11.7M -37.17% | 18.5M +41.51% | 13.1M -8.59% | 14.3M +8.25% | |
Total Current Assets | 48.7M -34.71% | 74.6M +64.01% | 45.5M -10.10% | 50.6M -8.63% | |
Accumulated Depreciation | 14.7M +22.81% | 12.0M -76.78% | 51.6M +25.65% | 41.0M +17.19% | |
Property and Plant and Equipment and Net | 104.7M +19.71% | 87.5M -6.93% | 94.0M -9.02% | 103.3M -8.27% | |
Total Long-Term Assets | 3.2M -36.23% | 5.0M +14.08% | 4.4M +14.66% | 3.8M -55.53% | |
Total Assets | 256.0M -5.56% | 271.0M -2.29% | 277.4M -8.59% | 303.5M -12.48% | |
Income Taxes Payable | N/A N/A | 0 -100.00% | 20.4M -14.29% | 23.8M -13.42% | |
Total Short-Term Debt | 0 -100.00% | 65,000 +18.18% | 55,000 +7.84% | 51,000 -99.97% | |
Total Current Liabilities | 68.5M -9.01% | 75.3M -39.97% | 125.4M +35.50% | 92.6M -67.61% | |
Total Long-Term Debt | 194.0M +6.43% | 182.3M +10.31% | 165.2M +12.20% | 147.3M +425.95% | |
Total Long-Term Liabilities | 2.9M -98.57% | 203.9M -12.90% | 234.1M +4.62% | 223.7M +101.87% | |
Total Liabilities | 359.0M +6.67% | 336.6M -0.73% | 339.1M +15.93% | 292.5M -20.77% | |
Retained Earnings | -1.4B +3.01% | -1.3B +0.58% | -1.3B +6.12% | -1.3B +56.30% | |
Total Stockholders Equity | -103.0M +57.21% | -65.5M +6.29% | -61.7M -661.16% | 11.0M +149.06% | |
Total Shares Outstanding | 6.9B +2.71% | 6.7B +102,478.41% | 6.5M -96.21% | 171.7M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 3.1M -74.92% | 12.5M +315.78% | 3.0M +115.47% | -19.5M -220.73% | |
Capital Expenditures | 23.8M +330.82% | 5.5M +54.51% | 3.6M -48.52% | 6.9M -64.31% | |
Cash from Investing Activities | 2.3M +136.57% | -6.3M +73.03% | -3.6M -23.42% | -4.7M -77.77% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -12.7M +3,638.05% | -339,000 -45.15% | -618,000 -102.80% | 22.1M +115.51% | |
Financials Ratio | |||||
Gross Margin | 45.63% +1.79% | 44.83% +13.00% | 39.67% -13.01% | 45.60% N/A | |
Operating Margin | -10.71% +110.76% | -5.08% -80.13% | -25.57% -62.89% | -68.90% N/A | |
Return on Assets | -15.26% +447.89% | -2.78% -89.44% | -26.38% -80.91% | -138.23% N/A | |
Return on Equity | 47.70% +297.28% | 12.01% -96.03% | 302.39% -96.16% | 7,878.52% N/A | |
Revenue Growth | -14.07% -369.01% | 5.23% +314.74% | -2.44% -87.58% | -19.61% N/A | |
Current Ratio | 0.71 -28.25% | 0.99 +173.24% | 0.36 -33.66% | 0.55 N/A | |
Cash Ratio | 0.17 -30.98% | 0.25 +135.69% | 0.10 -32.54% | 0.15 N/A | |
Debt-to-Equity Ratio | -1.88 -32.32% | -2.78 +3.79% | -2.68 -119.99% | 13.41 N/A | |
Debt-to-Assets Ratio | 0.76 +12.65% | 0.67 +12.91% | 0.60 +22.74% | 0.49 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow